Molecular analysis of episomal human papillomavirus type 16 DNA in a cervical carcinoma cell line

Virus Research

Volumn 51, Issue 2, 1997, Pages 183-195

  Hall, Wendy Sears ^a   Goto Mandeville, Ryoko ^a   Shih, Helen A ^a   Shank, Peter R ^b   Braun, Lundy ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cervical carcinogenesis; Episomal; Human papillomavirus type 16 (HPV16); Physical state; Transformation

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA DETERMINATION; DNA INTEGRATION; DNA SEQUENCE; EPISOME; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING; UTERINE CERVIX CARCINOMA; VIRUS CELL TRANSFORMATION; WART VIRUS;

ANIMALS; CELL LINE; CELL TRANSFORMATION, VIRAL; CLONING, MOLECULAR; DNA RESTRICTION ENZYMES; DNA, VIRAL; FEMALE; MICE; MICE, NUDE; PAPILLOMAVIRIDAE; PLASMIDS; RATS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS;

EID: 0031260141     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00095-6     Document Type: Article

References (48)

1. Baker, C.C., Phelps, W.C., Lindgren, V., Braun, M.J., Gonda, M.A., Howley, P.M., 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61, 962-971.
2. Bavin, P.J., Walker, P.O., Emery, V.C., 1993. Sequence microheterogeneity in the long control region of clinical isolates of human papillomavirus type 16. J. Med. Virol. 39, 267-272.
3. Bedell, M.A., Hudson, J.B., Golub, T.R., Turyk, M.E., Hosken, M., Wilbanks, G.D., Laimins, L.A., 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65, 2254-2260.
4. Berumen, J., Casas, L., Segura, E., Amezcua, J.L., Garcia-Carranca, A., 1994. Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int. J. Cancer 56, 640-645.
5. Bosch, F.X., Manos, M.M., Munoz, N., Sherman, M., Jansen, A.M., Peto, J., Schiffman, M.H., Moreno, V., Kurman, R., Shah, K.V., et al., 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87, 796-802.
6. Boshart, M., zur Hausen, H., 1986. Human papillomavirus in Buschke-Löwenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J. Virol. 58, 963-966.
7. Braun, L., Mikumo, R., Mark, H.F., Lauchlan, S., 1993. Analysis of the growth properties and physical state of the human papillomavirus type 16 genome in cell lines derived from primary cervical tumors. Am. J. Pathol. 143, 832-844.
8. Chan, W.-K., Klock. G., Bernard, H.-U., 1989. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J. Virol. 63, 3261-3269.
9. Chong, T., Apt, D., Gloss, B., Isa, M., Bernard, H.-U., 1991. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1 and AP-1 participate in epithelial cell-specific transcription. J. Virol. 65, 5933-5943.
10. Choo, K.-B., Pan, C.-C., Han, S.-H., 1987a. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 161, 259-261.
11. Choo, K.-B, Pan, C.-C., Liu, M.-S., Ng, H.-T., Chen, M.-Y., Lee, Y.-N., Chao, C.-F., Meng, C.-L., Yeh, M.-Y., Han, S.-H., 1987b. Presence of episomal and integrated human papillomavirus DNA sequences in cervical carcinoma. J. Med. Virol. 21, 101-107.
12. Choo, K.-B., Cheung, W.F., Liew, L.-N., Lee, H.-H., Han, S.-H., 1989. Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J. Virol. 63, 782-789.
13. Cripe, T.P., Haugen, T.H., Turk, J.P., Tabatabai, F., Schmid, P.G., Dürst, M., Gissman, L., Roman, A., Turek, L.P., 1987. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and represser gene products: implications for cervical carcinogenesis. EMBO J. 6, 3745-3753.
14. Crook, T., Greenfield, I., Howard, J., Stanley, M., 1990. Alterations in growth properties of human papillomavirus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene. Oncogene 5, 619-622.
15. Cullen, A.P., Reid, R., Campion, M., Lörincz, A.T., 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65, 606-612.
16. Das, B.C., Sharma, J.K., Gopalakrishna, V., Luthra, U.K., 1992. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol. 73, 2327-2336.
17. Del Vecchio, A.M., Romanczuk, H., Howley, P.M., Baker, C.C., 1992. Transient replication of human papillomavirus DNAs. J. Virol. 66, 5949-5958.
18. DiLorenzo, T., Taichman, L., Steinberg, B., 1992. Replication and persistence of HPV DNA in cultured cells derived from laryngeal papillomas. Virology 186, 148-153.
19. Di Luca, D., Caselli, E., Monini, P., Rotola, A., Savioli, A., Cassai, E., 1989. Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region. Virus Res. 14, 49-56.
20. DiPaolo, J.A., Popescu, N.C., Alvarez, L., Woodworth, C.D., 1993. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. Crit. Rev. Oncogenesis 4, 337-360.
21. Durst, M., Gissmann, L., Ikenberg, H., zur Hausen, H., 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA 80, 3812-3815.
22. Dürst, M., Kleinheinz, A., Hotz, M., Gissman, E., 1985. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J. Gen. Virol. 66, 1515-1522.
23. Fang, B.S., Guedes, A.C., Muñoz, L.C., Villa, L.L., 1993. Human papillomavirus type 16 variants isolated from vulvar bowenoid papulosis. J. Med. Virol. 41, 49-54.
24. Gloss, B., Yeo-Gloss, M., Meisterenst, M., Rogge, L., Winnacker, E.L., Bernard, H.-U., 1989. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res. 17, 3519-3533.
25. Hirt, B., 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
26. Jeon, S., Allen-Hoffman, B.L., Lambert, P.F., 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69, 2989-2997.
27. Jeon, S., Lambert, P.F., 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA. 92, 1654-1658.
28. Johnson, P.H., Grossmann, L.I., 1977. Electrophoresis of DNA in agarose gels. Optimizing separation of conformational isomers of double and single stranded DNAs. Biochemistry 16, 4217-4225.
29. Kennedy, I.M., Simpson, S., Macnab, J.C.M., Clements, J.B., 1987. Human papillomavirus type 16 DNA from a vulvar carcinoma in situ is present as head-to-tail dimeric episomes with a deletion in the non-coding region. J. Gen. Virol. 68, 451-462.
30. Maniatis, T., Fritsch, E.F., Sambrook, J., 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
31. Mark, H.F.L., Hann, E., Mikumo, R., Lauchlan, S., Beauregard, L., Braun, L., 1995. Cytogenetic characterization of three cell lines derived from primary cervical tumors. Ann. Clin. Lab. Sci. 25, 185-199.
32. Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A., Crawford, L., 1987. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6, 1741-1746.
33. Matsukura, T., Kanda, T., Furuno, A., Yoshikawa, H., Kawan, T., Yoskiike, K., 1986. Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J. Virol. 58, 979-982.
34. Matsukura, T., Koi, S., Sugase, M., 1989. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172, 63-72.
35. May, M., Dong, X.-P., Beyer-Finkler, E., Stubenrauch, F., Fuchs, P.G., Pfister, H., 1994. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13, 1460-1466.
36. Rando, R.F., Groff, D.E., Chirikjian, J.G., Lancaster, W.D., 1986. Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J. Virol. 57, 353-356.
37. 105 promoters. J. Virol. 64, 2849-2859.
38. Romanczuk, H., Villa, L.L., Schlegel, R., Howley, P.M., 1991. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65, 2739-2744.
39. Romanczuk, H., Howley, P.M., 1992. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. USA. 89, 3159-3163.
40. Rosen, M., Auborn, K., 1991. Duplication of the upstream regulatory sequences increases the transformation potential of human papillomavirus type 11. Virology 185, 484-487.
41. Seedorf, K., Krämmer, G., Dürst, M., Suhai, S., Röwekamp, W.G., 1985. Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
42. Shih, C., Weinberg, R., 1982. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29, 161-169.
43. Stanley, M.A., Browne, H.M., Appleby, M., Minson, A.C., 1989. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43, 672-676.
44. Stoler, M., Broker, T., 1986. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum. Pathol. 17, 1250-1258.
45. Taichman, L.B., LaPorta, R.F., 1987. The expression of papillomaviruses in epithelial cells. In: Salzman, N., Howley, P. (Eds.), The Papovaviridae: The Papillomaviruses. Plenum, New York, pp. 109-139.
46. 97 promoter is defined with HPV-associated cellular events in human epithelial cell lines. Virology 195, 500-510.
47. Wettstein, F.O., Stevens, J.G., 1982. Variable-sized free episomes of Shope papillomavirus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc. Natl. Acad. Sci. USA. 79, 790-794.
48. zur Hausen, H., 1996. Roots and perspectives of contemporary papillomavirus research. J. Cancer Res. Clin. Oncol. 122, 3-12.